Quest Diagnostics Inc
DUS:QDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Quest Diagnostics Inc
DUS:QDI
|
US |
|
Bluejay Diagnostics Inc
NASDAQ:BJDX
|
US |
|
A
|
Akar Auto Industries Ltd
BSE:530621
|
IN |
|
V
|
Vodafone Idea Ltd
NSE:IDEA
|
IN |
|
Reliance Home Finance Ltd
NSE:RHFL
|
IN |
|
M
|
Manning Ventures Inc
OTC:MANVF
|
CA |
|
Hargreaves Services PLC
LSE:HSP
|
UK |
|
A
|
Aventura Equities Inc
OTC:AVNE
|
US |
|
V
|
Vissem Electronics Co Ltd
KOSDAQ:072950
|
KR |
Wall Street
Price Targets
QDI Price Targets Summary
Quest Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for
QDI
is 189.75 EUR
with a low forecast of 145.45 EUR and a high forecast of 212.37 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is QDI's stock price target?
Price Target
189.75
EUR
According to Wall Street analysts, the average 1-year price target for
QDI
is 189.75 EUR
with a low forecast of 145.45 EUR and a high forecast of 212.37 EUR.
What is Quest Diagnostics Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Quest Diagnostics Inc's revenue is
3%.
The projected
CAGR
for the next 3 years is
5%.
What is Quest Diagnostics Inc's Operating Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Quest Diagnostics Inc's operating income is
2%.
The projected
CAGR
for the next 3 years is
9%.
What is Quest Diagnostics Inc's Net Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Quest Diagnostics Inc's net income is
5%.
The projected
CAGR
for the next 3 years is
12%.
